COMBIVIR

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

buyitnow

download PIL (PIL)
27-11-2018

active_ingredient:

LAMIVUDINE; ZIDOVUDINE

MAH:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC_code:

J05AF05

pharmaceutical_form:

FILM COATED TABLETS

composition:

LAMIVUDINE 150 MG; ZIDOVUDINE 300 MG

administration_route:

PER OS

prescription_type:

Required

manufactured_by:

GLAXO SMITH KLINE PHARMACEUTICALS S.A., POLAND

therapeutic_area:

LAMIVUDINE

therapeutic_indication:

Combivir is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection.

authorization_date:

2015-10-20

PIL

                                רבמבונ
2018 :ןודנה
ריויבמוק
תופוצמ תוילבט
FILM COATED TABLETS
COMBIVIR
ה/דבכנ ה/אפור
,ה/דבכנ ת/חקור
( מ"עב לארשי ןיילקתימסוסקלג תרבח
GSK
ולעה ןוכדע לע עידוהל תשקבמ )
ן
אפורל
לש
רישכתה
COMBIVIR
םייונישה םילולכ וז העדוהב
םייתוהמה
אפורל ןולעב
.
.ןכרצל ןולעב יוניש ןיא
:םקזוחו םיליעפ םיביכרמ
Lamivudine – 150 mg
Zidovudine – 300 mg :לארשיב רישכתל המושרה היוותה
Combivir is indicated in antiretroviral combination therapy for the
treatment of Human
Immunodeficiency Virus (HIV) infection.
ה
ע םינוכד
נ םיאבה םיפיעסב ושע
ב
: אפורל ןולע
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
…
_Immune Reactivation Syndrome:_
…Autoimmune disorders (such as Graves’ disease and autoimmune
hepatitis) have also been reported to occur
in the setting of immune reactivation; however, the reported time to
onset is more variable and these events
can occur many months after initiation of treatment.
_ _
…
4.8
UNDESIRABLE EFFECTS
…
In HIV-infected patients with severe immune deficiency at the time of
initiation of combination antiretroviral
therapy (CART), an inflammatory reaction to asymptomatic or residual
opportunistic infections may arise.
Autoimmune disorders (such as Graves’ disease and autoimmune
hepatitis) have also been reported to occur
in the setting of immune reactivation; however, the reported time to
onset is more variable and these events
can occur many months after initiation of treatment (see section 4.4).
…
: םינמוסמה םינוכדעל ארקמ
רסוהש עדימ
–
הצוח םודא וקב ןמוסמ
XXX
תפסות
–
בתכ
לוחכ
הרמחה תפסות
-
בתכ
לוחכ
–
רקרמ בוהצב ןמוסמ
ולעה
ן
אפורל
חלשנ
םוסרפל
רגאמב
תופורתה
רתאבש
דרשמ
תואירבה
:
https://www.old.health.gov.il/units/pharmacy/tr
                                
                                read_full_document
                                
                            

documents_in_other_languages

PIL PIL արաբերեն 17-02-2019
PIL PIL եբրայերեն 17-02-2019

view_documents_history